Atrás
Rango del Día
$4.03
$4.40
Rango de 52 Semanas
$1.00
$5.82
Volumen
250
Promedio 50D / 200D
$4.89
/
$4.18
Cierre Anterior
$4.03
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (626 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -9.0 | 0.4 |
| P/B | — | 2.9 |
| ROE % | — | 3.7 |
| Net Margin % | -50.7 | 3.8 |
| Rev Growth 5Y % | 58.2 | 10.0 |
| D/E | — | 0.2 |
Puntos Clave
Revenue grew 58.15% annually over 5 years — strong growth
Negative free cash flow of -167.05M
PEG of 0.12 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 38.37%
Capital efficient — spends only 6.25% of revenue on capex
Crecimiento
Revenue Growth (5Y)
58.15%
Revenue (1Y)96.52%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
N/A
ROIC-67.16%
Net Margin-50.68%
Op. Margin-52.64%
Seguridad
Debt / Equity
N/A
Current Ratio1.39
Interest Coverage-2.73
Valoración
P/E Ratio
-8.95
P/B RatioN/A
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 96.52% | Revenue Growth (3Y) | 20.46% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 58.15% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 221.11M | Net Income (TTM) | -112.05M |
| ROE | N/A | ROA | -24.05% |
| Gross Margin | 90.31% | Operating Margin | -52.64% |
| Net Margin | -50.68% | Free Cash Flow (TTM) | -167.05M |
| ROIC | -67.16% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 1.39 |
| Interest Coverage | -2.73 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -8.95 | P/B Ratio | N/A |
| P/S Ratio | 4.54 | PEG Ratio | 0.12 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 1.00B | Enterprise Value | 2.18B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 221.11M | 112.51M | 152.39M | 97.10M | 35.35M |
| Net Income | -112.05M | -263.76M | -297.92M | -827.90M | -634.60M |
| EPS (Diluted) | -0.52 | -1.45 | -1.67 | -4.67 | -3.77 |
| Gross Profit | 199.67M | 76.58M | 145.24M | 90.84M | 17.32M |
| Operating Income | -116.38M | -232.01M | -255.15M | -802.97M | -613.00M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 465.88M | 505.90M | 500.00M | 904.18M | 1.48B |
| Total Liabilities | 1.60B | 1.72B | 1.47B | 1.57B | 1.38B |
| Shareholders' Equity | -1.14B | -1.21B | -968.72M | -660.96M | 104.20M |
| Total Debt | 1.27B | 1.26B | 1.20B | 1.23B | 1.16B |
| Cash & Equivalents | 87.24M | 105.38M | 145.05M | 146.00M | 101.35M |
| Current Assets | 223.81M | 255.48M | 276.28M | 596.44M | 1.08B |
| Current Liabilities | 160.86M | 443.20M | 301.33M | 170.36M | 165.14M |